Guest guest Posted January 25, 2004 Report Share Posted January 25, 2004 Dec 16, 2003 Screen for vitamin-D deficiency in all patients with persistent, nonspecific musculoskeletal pain Rochester, MN - Screening all patients presenting with persistent, nonspecific musculoskeletal pain for vitamin-D deficiency should be a standard practice in clinical care, say US researchers, writing in the December 2003 issue of the Mayo Clinic Proceedings [1]. They report on a study carried out at an inner-city primary-care clinic affiliated with the University of Minnesota, in which 93% of outpatients presenting with such pain were found to be vitamin-D deficient, many severely so. Five patients had undetectable levels of vitamin D, and all of the patients under 30 years of age (n=33) were deficient. " These findings are remarkably different from what is taught at medical school. We would expect vitamin-D deficiency in old persons or the housebound, " says lead researcher Dr Greg Plotnikoff (University of Minnesota, Minneapolis; currently at Keio University, Tokyo, Japan). " We found the worst vitamin-D deficiency in young personsespecially women of childbearing age. We were stunned to find no vitamin D at all in 5 patients who had been told their pain was 'all in their head.' " All of the patients were at risk of misdiagnosis and suboptimal treatment of their pain condition, the researchers note. Severe deficiency of vitamin D is not asymptomatic, they comment: it results in a syndrome of persistent, nonspecific musculoskeletal pain, even before the clinical manifestation of osteomalacia bone pain. Inadequate mineralization of bone Vitamin-D deficiency causes muscle weakness and muscle aches and pains in both adults and children, comments Dr Holick (Boston University School of Medicine, MA) in an accompanying editorial [2]. The lack of vitamin D leads, via parathyroid hormone and calcium, to inadequate mineralization of the bone, so that the collagen matrix becomes rubbery, and in hydrating and expanding it exerts an outward pressure on sensory nerves. " This is the likely explanation of why patients with osteomalacia often experience a dull, unrelenting aching sensation in their bones, " Holick says, but he points out that " these symptoms are either dismissed or misdiagnosed as fibromyalgia by many physicians. " " A physical examination that includes application of minimal pressure with the thumb or forefinger on the sternum, anterior tibia, or radius and ulna often will elicit pain and discomfort, which is a helpful diagnostic sign for osteomalacia, " he adds. Vitamin-D deficiency has again become a major health problem Plotnikoff et al's finding of vitamin D deficiency is " newsworthy " but is not unexpected, Holick comments in the editorial, citing several other recent studies that have found vitamin-D deficiency in US populations. " It is inconceivable with all the advances in modern medicine that vitamin-D deficiency should be a health concern in the US, " he writes. Most physicians assume that vitamin-D deficiency, which plagued children in the 17th through 19th centuries, has been eradicated, but it has again become a major health problem for all ages and races. " All physicians should be alert to vitamin-D deficiency. " There are a multitude of reasons for this, he comments. Extremely few foods naturally contain vitamin D, and fortification of foodstuffs with the vitamin was abandoned after an outbreak of vitamin-D intoxication during the 1950s (in a limited number of children in the UK). Most vitamin D (90% or more) comes from exposure to sunlight, but this has been discouraged in recent years by health-education messages aimed at preventing skin cancer. Some of these advise avoiding all direct exposure to the sun and always using a sunscreen when outdoors, but a sun protection factor of 8 reduces the capacity of the skin to produce vitamin D by 95%, Holick points out. All physicians should be alert to vitamin-D deficiency, Holick says. Patients should have their vitamin-D status tested once a year, preferably at the end of the fall season, to ensure that they do not become vitamin-D deficient before winter. Study finds severe deficiency of vitamin D Plotnikoff et al investigated 150 patients (ranging from 10 to 65 years old) who presented with persistent, nonspecific musculoskeletal pain. None of these patients had fibromyalgia, temporomandibular disorder, or complex regional pain syndrome, and none had any known medical condition that would interfere with the production or absorption of vitamin D, they note. They measured serum levels of 25-hydroxyvitamin D, a standard marker for vitamin-D status. As there is no universal consensus about what level constitutes vitamin-D deficiency, the researchers used a physiological definition of 20 ng/mL (50 nmol/L) or lessbelow this, serum levels of parathyroid hormone (PTH) increase, and even slight increases in serum PTH result in increased bone turnover and accelerated bone loss. Overall, 140 of 150 patients (93%) were found to have deficient levels of vitamin D, regardless of immigrant status, sex, race, or season. Mean serum levels of 25-hydroxyvitamin D were 12.08 ng/mL, which is in the moderately severe to moderately deficient range, the researchers comment. Previous studies have identified vitamin-D deficiency in immigrant populations, they note. In their own study, just over half of the patients were from immigrant populations. Among these, vitamin-D deficiency was found in all (100%) of the East African (n=34) and Hispanic (n=5) individuals and in 89% (39/44) of Southeastern Asians. The researchers comment that, unexpectedly, they also found vitamin-D deficiency in all of the African American (n=22) and American Indian (n=10) individuals and in 83% (29/35) of white patients. The degree of severity of vitamin-D deficiency was inversely disproportionate by age groups. All of the younger patients (6 of whom were aged 10 to 19, 27 aged 20 to 29) were deficient and had significantly lower levels of serum 25-hydroxyvitamin D (mean 9.18 ng/mL) than those aged 50 or more (mean 13.3 ng/mL). These young adults are at high risk of failure to develop optimal peak bone mass, the researchers comment. Women of childbearing age had significantly lower levels (mean 9.56 ng/mL) than older women (14.09 ng/mL), and the level of deficiency found in these younger women puts them at risk of bearing children with adverse fetal effects or severe neonatal illness. Nearly half of these younger women were severely or profoundly vitamin-D deficient, they note. Men were equally deficient (mean 11.72 ng/mL), even though they accounted for only 29% (44/150) of the study participants. Of the 5 patients who had undetectable levels of 25-hydroxyvitamin D, 4 were under 35 years of age and 3 were nonimmigrants (1 was a white 23-year-old female, 2 were African American). All of these patients had had extensive contact with the healthcare system and had been variously diagnosed with dysthymia, joint disease, stress reaction, and/or major depressive disorder; all were taking nonsteroidal anti-inflammatory drugs (NSAIDs), and 2 were also on antidepressants. In none of these patients was osteomalacia suspected. " The presence of nearly universal hypovitaminosis D in Minnesota cannot be ruled out. " Discussing the limitations of their study, Plotnikoff et al point out that they took only 1 measurement and investigated only patients with nonspecific musculoskeletal painthey did not have matched controls in the general population. They also note that the level of vitamin D found in their study is much lower than those reported in other studies, even in 1 study that looked specifically at patients with painful conditions (fibromyalgia and systemic lupus erythematosus) and was conducted at a geographically similar latitude (and hence similar sunshine levels). Nevertheless, the findings may reflect the background prevalence of hypovitaminosis D, and the presence of nearly universal hypovitaminosis D in Minnesota cannot be ruled out, the researchers caution. Screen all patients with musculoskeletal pain " These results support screening of all outpatients with persistent, nonspecific musculoskeletal pain for hypovitaminosis D. These patients are at high risk for the consequences of unrecognized and untreated hypovitaminosis D, " say Plotnikoff et al. The findings of this study show that those at risk include populations who have, until now, been considered low risk, including nonelderly, nonhousebound, and nonimmigrant patients of either sex. Nonimmigrant women of childbearing age may be at particularly high risk, they add. " Vitamin D deficiency has again become a major health problem for all ages and races. " " Because osteomalacia is a known cause of persistent, nonspecific musculoskeletal pain, screening all outpatients with such pain for hypovitaminosis D should be standard practice in clinical care, " the researchers conclude. " A prospective US trial to assess management of persistent, nonspecific pain by prescription vitamin-D replenishment is urgently needed, " they add. Take-home message: measure vitamin D " The take-home message from Plotnikoff and Quigley's observations is that when patients with nonspecific skeletomuscular pain are evaluated, their serum 25-hydroxyvitamin D levels should be obtained, " says Holick in the editorial. " Physicians should discard the laboratory-reported lower limit of the normal range. A serum 25-hydroxyvitamin D level of at least 20 ng/mL is necessary to minimally satisfy the body's vitamin-D requirement. Maintenance of a serum level of 25-hydroxyvitamin D of 30 to 50 ng/mL is preferred. " Zosia Chustecka Sources 1. Plotnikoff GA, Quigley JM. Prevalence of severe hypovitaminosis D in patients with persistent, nonspecific musculoskeletal pain. Mayo Clin Proc 2003 Dec; 78(12):1463-70. 2. Holick MF. Vitamin D deficiency: what a pain it is. Mayo Clin Proc 2003 Dec; 78(12):1457-9. Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.